127 related articles for article (PubMed ID: 33548366)
1. A moving-boundary model of dissolution from binary drug-excipient granules incorporating microstructure.
Moroney KM; Kotamarthy L; Muthancheri I; Ramachandran R; Vynnycky M
Int J Pharm; 2021 Apr; 599():120219. PubMed ID: 33548366
[TBL] [Abstract][Full Text] [Related]
2. Combined UV/vis and micro-tomography investigation of acetaminophen dissolution from granules.
Kašpar O; Tokárová V; Oka S; Sowrirajan K; Ramachandran R; Štěpánek F
Int J Pharm; 2013 Dec; 458(2):272-81. PubMed ID: 24409518
[TBL] [Abstract][Full Text] [Related]
3. Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.
Casas M; Aguilar-de-Leyva Á; Caraballo I
Int J Pharm; 2015 Oct; 494(1):288-95. PubMed ID: 26253376
[TBL] [Abstract][Full Text] [Related]
4. Switch of tablet manufacturing from high shear granulation to twin-screw granulation using quality by design approach.
Miyazaki Y; Lenhart V; Kleinebudde P
Int J Pharm; 2020 Apr; 579():119139. PubMed ID: 32061724
[TBL] [Abstract][Full Text] [Related]
5. Formulation of a poorly water-soluble drug in sustained-release hollow granules with a high viscosity water-soluble polymer using a fluidized bed rotor granulator.
Asada T; Yoshihara N; Ochiai Y; Kimura SI; Iwao Y; Itai S
Int J Pharm; 2018 Apr; 541(1-2):246-252. PubMed ID: 29496456
[TBL] [Abstract][Full Text] [Related]
6. Surface dissolution UV imaging for characterization of superdisintegrants and their impact on drug dissolution.
Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
Int J Pharm; 2020 Mar; 577():119080. PubMed ID: 31988030
[TBL] [Abstract][Full Text] [Related]
7. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
Košir D; Vrečer F
Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceutical implications of excipient variability on drug dissolution from immediate release products.
Zarmpi P; Flanagan T; Meehan E; Mann J; Østergaard J; Fotaki N
Eur J Pharm Biopharm; 2020 Sep; 154():195-209. PubMed ID: 32681966
[TBL] [Abstract][Full Text] [Related]
9. A comparison of drug loading capacity of cellactose with two ad hoc processed lactose-cellulose direct compression excipients.
Casalderrey M; Souto C; Concheiro A; Gómez-Amoza JL; Martínez-Pacheco R
Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):398-401. PubMed ID: 15056951
[TBL] [Abstract][Full Text] [Related]
10. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
11. An investigation on the correlation between drug dissolution properties and the growth behaviour of granules in high shear mixer.
Guo Z; Ma M; Hao Y; Jiang T; Wang S
J Pharm Pharmacol; 2011 Dec; 63(12):1548-58. PubMed ID: 22060285
[TBL] [Abstract][Full Text] [Related]
12. Characterization and taste-masking evaluation of acetaminophen granules: comparison between different preparation methods in a high-shear mixer.
Albertini B; Cavallari C; Passerini N; Voinovich D; González-Rodríguez ML; Magarotto L; Rodriguez L
Eur J Pharm Sci; 2004 Feb; 21(2-3):295-303. PubMed ID: 14757501
[TBL] [Abstract][Full Text] [Related]
13. A study of the impact of excipient shielding on initial drug release using UV imaging.
Hiew TN; Alaudin MIB; Chua SM; Heng PWS
Int J Pharm; 2018 Dec; 553(1-2):229-237. PubMed ID: 30339946
[TBL] [Abstract][Full Text] [Related]
14. HIGH SHEAR GRANULATION PROCESS: ASSESSING IMPACT OF FORMULATION VARIABLES ON GRANULES AND TABLETS CHARACTERISTICS OF HIGH DRUG LOADING FORMULATION USING DESIGN OF EXPERIMENT METHODOLOGY.
Fayed MH; Abdel-Rahman SI; Alanazi FK; Ahmed MO; Tawfeek HM; Ali BE
Acta Pol Pharm; 2017 Mar; 74(2):551-564. PubMed ID: 29624260
[TBL] [Abstract][Full Text] [Related]
15. Studies on the compressibility of wax matrix granules of acetaminophen and their admixtures with various tableting bases.
Uhumwangho MU; Okor RS
Pak J Pharm Sci; 2006 Apr; 19(2):103-7. PubMed ID: 16751119
[TBL] [Abstract][Full Text] [Related]
16. Saturated phosphatidylcholine as matrix former for oral extended release dosage forms.
Kolbina M; Bodmeier R; Körber M
Eur J Pharm Sci; 2017 Oct; 108():86-92. PubMed ID: 28716757
[TBL] [Abstract][Full Text] [Related]
17. The effects of formulation factors on the moist granulation technique for controlled-release tablets.
Railkar AM; Schwartz JB
Drug Dev Ind Pharm; 2001 Oct; 27(9):893-8. PubMed ID: 11763466
[TBL] [Abstract][Full Text] [Related]
18. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.
Williams RO; Reynolds TD; Cabelka TD; Sykora MA; Mahaguna V
Pharm Dev Technol; 2002 May; 7(2):181-93. PubMed ID: 12066573
[TBL] [Abstract][Full Text] [Related]
19. The granule porosity controls the loss of compactibility for both dry- and wet-processed cellulose granules but at different rate.
Nordström J; Alderborn G
J Pharm Sci; 2015 Jun; 104(6):2029-2039. PubMed ID: 25872760
[TBL] [Abstract][Full Text] [Related]
20. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
